🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
This is a prospective, single-arm clinical study to evaluate the efficacy a...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2022-02-01
Trial ID
NCT07493486
Treatments Being Tested
This pilot phase I trial studies the side effects of pembrolizumab and comb...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-11-24
Trial ID
NCT02541565
The goal of the study is to identify a dose and schedule of CC-486 that can...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2015-04-29
Trial ID
NCT02343536
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of surovatam...
Status
Recruiting
Location
Research Site
Start Date
2025-01-30
Trial ID
NCT06564038
To evaluate the feasibility of adding induction and maintenance Avelumab to...
Status
Unknown
Location
Ballarat Health
Start Date
2017-07-21
Trial ID
NCT03244176
Treatments Being Tested
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
This study aims to compare the efficacy and safety of Polatuzumab Vedotin, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06516978
This was a single center, single arm, phase II study. Patients with previou...
Status
Recruiting
Location
Tianjin Cancer Hospital
Start Date
2024-12-20
Trial ID
NCT06704555
Treatments Being Tested